Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Heinzer

Showing results (31-40 of 145) with videos related to

Pageof 15
Sort By:
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|May 7, 2024
Impact of COVID-19 on the time to counseling and treatment of prostate cancerDejan K Filipas, Randi M Pose, Phillip Marks, et al.
European Urology Focus|November 14, 2017
Assessment of Oncological Outcomes After Radical Prostatectomy According to Preoperative and Postoperative Cancer of the Prostate Risk Assessment Scores: Results from a Large, Two-center ExperienceSami-Ramzi Leyh-Bannurah, Paolo Dell'Oglio, Emanuele Zaffuto, et al.
BJU International|March 31, 2019
A comparative study of robot-assisted and open radical prostatectomy in 10 790 men treated by highly trained surgeons for both proceduresAlexander Haese, Sophie Knipper, Hendrik Isbarn, et al.
BJU International|October 17, 2013
Open and robot-assisted radical retropubic prostatectomy in men receiving ongoing low-dose aspirin medication: revisiting an old paradigm?Sami-Ramzi Leyh-Bannurah, Jens Hansen, Hendrik Isbarn, et al.
Journal of Proteomics|March 1, 2015
Prostate cancer-associated autoantibodies in serum against tumor-associated antigens as potential new biomarkersRamesh Ummanni, Divya Duscharla, Christine Barett, et al.
Oncotarget|December 20, 2015
Heterogeneity and chronology of 6q15 deletion and ERG-fusion in prostate cancerMartina Kluth, David Meyer, Antje Krohn, et al.
BJU International|February 26, 2015
Salvage radical prostatectomy for recurrent prostate cancer: verification of European Association of Urology guideline criteriaPhilipp Mandel, Thomas Steuber, Sascha Ahyai, et al.
BJU International|April 24, 2012
Risk assessment of metastatic recurrence in patients with prostate cancer by using the Cancer of the Prostate Risk Assessment score: results from 2937 European patientsLars Budäus, Hendrik Isbarn, Pierre Tennstedt, et al.
Urologic Oncology|October 24, 2020
Oncological outcomes of pathologically organ-confined, lymph node-positive prostate cancer after radical prostatectomyLara Franziska Stolzenbach, Sophie Knipper, Philipp Mandel, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 18, 2012
Marked heterogeneity of ERG expression in large primary prostate cancersSarah Minner, Michael Gärtner, Fabian Freudenthaler, et al.
Pageof 15

Showing results (31-40 of 145) with videos related to

Sort By:
Pageof 15
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|May 7, 2024
Impact of COVID-19 on the time to counseling and treatment of prostate cancerDejan K Filipas, Randi M Pose, Phillip Marks, et al.
European Urology Focus|November 14, 2017
Assessment of Oncological Outcomes After Radical Prostatectomy According to Preoperative and Postoperative Cancer of the Prostate Risk Assessment Scores: Results from a Large, Two-center ExperienceSami-Ramzi Leyh-Bannurah, Paolo Dell'Oglio, Emanuele Zaffuto, et al.
BJU International|March 31, 2019
A comparative study of robot-assisted and open radical prostatectomy in 10 790 men treated by highly trained surgeons for both proceduresAlexander Haese, Sophie Knipper, Hendrik Isbarn, et al.
BJU International|October 17, 2013
Open and robot-assisted radical retropubic prostatectomy in men receiving ongoing low-dose aspirin medication: revisiting an old paradigm?Sami-Ramzi Leyh-Bannurah, Jens Hansen, Hendrik Isbarn, et al.
Journal of Proteomics|March 1, 2015
Prostate cancer-associated autoantibodies in serum against tumor-associated antigens as potential new biomarkersRamesh Ummanni, Divya Duscharla, Christine Barett, et al.
Oncotarget|December 20, 2015
Heterogeneity and chronology of 6q15 deletion and ERG-fusion in prostate cancerMartina Kluth, David Meyer, Antje Krohn, et al.
BJU International|February 26, 2015
Salvage radical prostatectomy for recurrent prostate cancer: verification of European Association of Urology guideline criteriaPhilipp Mandel, Thomas Steuber, Sascha Ahyai, et al.
BJU International|April 24, 2012
Risk assessment of metastatic recurrence in patients with prostate cancer by using the Cancer of the Prostate Risk Assessment score: results from 2937 European patientsLars Budäus, Hendrik Isbarn, Pierre Tennstedt, et al.
Urologic Oncology|October 24, 2020
Oncological outcomes of pathologically organ-confined, lymph node-positive prostate cancer after radical prostatectomyLara Franziska Stolzenbach, Sophie Knipper, Philipp Mandel, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 18, 2012
Marked heterogeneity of ERG expression in large primary prostate cancersSarah Minner, Michael Gärtner, Fabian Freudenthaler, et al.
Pageof 15